ESC and EHRA lead a path towards integrated care for multimorbid atrial fibrillation patients: the Horizon 2020 EHRA-PATHS project

Eur Heart J. 2022 Apr 14;43(15):1450-1452. doi: 10.1093/eurheartj/ehab672.

Authors

Hein Heidbuchel^{1

2

3}, Isabelle C Van Gelder⁴, Lien Desteghe^{1

2

3}; EHRA-PATHS Investigators

Affiliations

¹ Cardiovascular Research, Antwerp University, Universiteitsplein 1, Antwerp, Wilrijk 2610, Belgium.
² Department of Cardiology, Antwerp University Hospital, Drie Eikenstraat 655, Antwerp 2650, Belgium.
³ Hasselt University, Agoralaan, gebouw D, Diepenbeek 3590, Belgium.
⁴ University of Groningen, University Medical Center Groningen, Hanzeplein 1, P.B. 30.001, Groningen 9700 RB, The Netherlands.

PMID: 34694355
DOI: 10.1093/eurheartj/ehab672

No abstract available

MeSH terms

Anticoagulants
Atrial Fibrillation* / therapy
Delivery of Health Care, Integrated*
Humans
Thromboembolism*

Substances

Anticoagulants

Grants and funding

945260/European Union's Horizon 2020 research and innovation programme